March 20, 2020 / 9:54 AM / 8 days ago

BRIEF-Sino Biopharmaceutical Says Dabigatran Etexilate Capsules Developed By Unit Gets Approval For Drug Registration Granted By NMPA

March 20 (Reuters) - Sino Biopharmaceutical Ltd:

* SINO BIOPHARMACEUTICAL LTD- DABIGATRAN ETEXILATE CAPSULES DEVELOPED BY UNIT OBTAINED APPROVAL FOR DRUG REGISTRATION GRANTED BY NMPA OF PRC Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below